Last reviewed · How we verify

NCT05757362

Development of Compliance Questionnaire for Home Exercise Program

Completed NA Last updated 2 May 2025
What this trial tests

NA trial testing Compliance Questionnaire for Therapeutic Home Exercise Program in Physiotherapy and Rehabilitation (cq-HEPT) in Development, Consensus in 50 participants. Completed in 1 September 2024.

Timeline
24 April 2023
Primary endpoint
25 June 2023
1 September 2024

Quick facts

Lead sponsorIstanbul Bilgi University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment50
Start date24 April 2023
Primary completion25 June 2023
Estimated completion1 September 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Bilgi University

Who can join

18 and older, any sex, with Development, Consensus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exercise is a valuable basic treatment method in the field of physiotherapy and rehabilitation. However, the effectiveness of exercise therapy requires the individual to be attentive, compliant, and disciplined. Therefore, it is important to examine the factors that may affect compliance with exercise. The main aim of this study is to develop a questionnaire that can describe individuals' compliance with participation in a home exercise program using the Delphi method and then analyze the psychometric validity and reliability of this questionnaire. The value that the evaluation questionnaire planned to be obtained at the end of such a study will add to exercise science, which is one of the most powerful treatment elements of physiotherapy and rehabilitation discipline, is important.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Bilgi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05757362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing